GlassScriptPhysician profile
Madison Alberts
NPI 1629899893
$1,365.45
in general payments reported to CMS, 2019-2025
14 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $151 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.46 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $286.41 | 2025 | Tremfya |
| Genzyme Corporation | $210.84 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $152.48 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $145.39 | 2025 | |
| Arcutis Biotherapeutics, INC. | $144.19 | 2025 | Zoryve |
| Ucb, INC. | $127.38 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $78.72 | 2024-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $66.47 | 2025 | |
| Mayne Pharma Commercial LLC | $33.83 | 2025 | |
| Mimedx Group, INC. | $26.94 | 2025 | |
| Verrica Pharmaceuticals INC. | $25.84 | 2025 | Ycanth |
| Organon LLC | $23.11 | 2024 | |
| Amgen INC. | $22.71 | 2025 | Otezla |
| Surgenex LLC | $21.14 | 2025 | Ardeograft, Surgraft, Pellograft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Alberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.